Personalized tumor vaccine for pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-313Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2022-06-17 / Pharm Res 2022 Aug;39(8):1851-1866Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-06-16 / BMJ Open 2022 Jun;12(6):e060431Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-06-03 / Cancer Immunol Res 2022 Jun;10(6):728-744Autologous Dendritic Vaccine Therapy in Metastatic Kidney Cancer: The ADAPT Trial and Beyond
/in Dendritic Cells, Hypernephroma, International Publications /von 2022-05-31 / Eur Urol Focus 2022 May;8(3):651-653Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-1441Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-04-28 / Eur J Cancer 2022 Jul;169:20-31Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2022-03-10 / Ther Apher Dial 2022 Jun;26(3):537-547A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysis
/in Dendritic Cells, Glioblastoma, International Publications /von 2022-03-08 / Expert Rev Vaccines 2022 Apr;21(4):513-531
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de